Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESG Concept

2,820.22
+87.693.21%
Number of Gainers:40
Number of Losers:3
Number of Flat:1
PE:- -
High:2,823.46
Open:2,731.69
Low:2,731.69
Close:2,732.53
Loading ...

Vertex Pharmaceuticals announces MHRA approval of ALYFTREK for CF

TIPRANKS
·
07 Mar

Vertex Pharmaceuticals Inc - Working With Nice and Nhs for Alyftrek Access

THOMSON REUTERS
·
07 Mar

Vertex Announces UK Mhra Approval of Alyftrek® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class Cftr Modulator for the Treatment of Cystic Fibrosis

THOMSON REUTERS
·
07 Mar

Do Its Financials Have Any Role To Play In Driving Fastenal Company's (NASDAQ:FAST) Stock Up Recently?

Simply Wall St.
·
07 Mar

THE MEXICO FUND, INC. DECLARES DISTRIBUTION

PR Newswire
·
07 Mar

COTY Stock Plunges More Than 25% in 3 Months: What Should You Do?

Zacks
·
07 Mar

Is the Options Market Predicting a Spike in Applied Materials (AMAT) Stock?

Zacks
·
07 Mar

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks
·
07 Mar

InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

GlobeNewswire
·
07 Mar

Vertex Pharmaceuticals' Triple Combination Cystic Fibrosis Therapy Alyftrek Receives Approval in UK

MT Newswires Live
·
07 Mar

Analysts Have Conflicting Sentiments on These Industrial Goods Companies: GFL Environmental (GFL), Joby Aviation (JOBY) and Fastenal Company (FAST)

TIPRANKS
·
07 Mar

BRIEF-UK's MHRA Approves Triple Combination Of Deutivacaftor/Tezacaftor/Vanzacaftor For Cystic Fibrosis

Reuters
·
07 Mar

UK's Mhra Says Triple Combination Medicine Deutivacaftor/Tezacaftor/Vanzacaftor Approved for Cystic Fibrosis

THOMSON REUTERS
·
07 Mar

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
07 Mar

It's retailers' turn to be 'resilient': Morning Brief

Yahoo Finance
·
07 Mar

Elia Group Announces EUR 2.2 Bln Equity Package

Reuters
·
07 Mar